Current Therapeutic Strategies in MASH: Lifestyle and Pharmacologic Interventions

Sun, Nov 8, 2026 · 11:00 AM–12:30 PM MST Convention Center: Bluebird Ballroom 1A, Colorado Convention Center

About this session

This session examines pharmacologic (GLP-1 agonists, resmetirom) and lifestyle-based interventions for MASH/MASLD across adult and pediatric populations, including transplant recipients. <h2 class="objectives__heading d-flex flex-column font-barlow fs-xxxl fw-bold font-style-italic text-uppercase lh-headings text-dark-green"